ABSTRACT
Antimicrobial resistance (AMR) alarms the effective control and treatment of growing infections of bacterial, parasitic, viral, and fungal infections. This report, for the initial stage, examines the current state of monitoring and information regarding AMR at the global country level, particularly antibacterial resistance (ABR). The main research and public health effects of ABR; high rates of resistance to bacteria causing common health-care-related and community-acquired infections (e.g., urinary tract infections, pneumonia) have been perceived in all WHO areas. There are significant gaps in monitoring and a lack of criteria for methods, data splitting, and coordination. The key findings from AMR scrutiny in disease-specific programs are as; while multidrug-resistant TB is an enlarging concern, it has been reported in most cases blank, compromising control efforts. Artemisinin resistance foci in malaria have been picked out in several countries. Further spread or emergence of artemisinin-resistant strains in other regions could jeopardize recent attains in malaria prevention.
Keywords: Exploration, Antimicrobial resistance, Remedy, Living world, TB, Treatment, and Antibacterial.
Citation: Rahamn MA, Rahman B, Ahammed T, and Sharif IH. (2020). Exploration of the antimicrobial resistance and their remedy in living world: a brief study, Eur. J. Med. Health Sci., 2(5), 86-100.
https://doi.org/10.34104/ejmhs.020.0860100
